Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer. [PDF]
, 2018 BACKGROUND: Intravenous ascorbic acid (IV AA) has been used extensively in cancer patients throughout the United States. Currently, there are limited data on the safety and clinical effects of IV AA.
Bazzan, Anthony J. +4 more
core +2 more sources
Risk factors associated with antineoplastic chemotherapy-induced nausea and vomiting
Revista de Saúde Pública, 2020 OBJECTIVE: To estimate the incidence and to evaluate risk factors for antineoplastic nausea and vomiting with high and moderate emetogenic chemotherapy in adult patients in the first treatment cycle.
Giovana Paula Rezende Simino +5 more
doaj +2 more sources
Anti-emetic effects of thalidomide: Evidence, mechanism of action, and future directions
Current Research in Pharmacology and Drug Discovery, 2022 The rationale for using thalidomide (THD) as a treatment for nausea and vomiting during pregnancy in the late 1950s appears to have been based on its sedative or hypnotic properties.
Paul L.R. Andrews +2 more
doaj +1 more source
Efficacy of ginger (Zingiber officinale) in ameliorating chemotherapy-induced nausea and vomiting and chemotherapy-related outcomes: a systematic review update and meta-analysis [PDF]
, 2019 Background: Ginger has been proposed as an adjuvant treatment for chemotherapy-induced nausea and vomiting. Objective: The aim of this systematic review with meta-analyses is to evaluate, in adult cancer patients receiving chemotherapy, the effects of ...
Crichton, Megan +4 more
core +1 more source
Evidence-Based Complementary and Alternative Medicine, 2021 Background More than 40% of patients with cancer have reported that chemotherapy-induced nausea and vomiting (CINV) remained the most debilitating side effects of treatment even in the era of new antiemetics.
Lichan Chen +3 more
semanticscholar +1 more source
Motion sickness, stress and the endocannabinoid system [PDF]
, 2010 A substantial number of individuals are at risk for the development of motion sickness induced nausea and vomiting (N&V) during road, air or sea travel.
Choukèr, Alexander +8 more
core +3 more sources
International Journal of Clinical Oncology, 2020 Patients with cancer should appropriately receive antiemetic therapies against chemotherapy-induced nausea and vomiting (CINV). Antiemetic guidelines play an important role in managing CINV.
K. Aogi +26 more
semanticscholar +1 more source
Effect of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Women
JAMA Network Open, 2021 Key Points Question Is prophylactic aprepitant therapy combined with palonosetron and dexamethasone effective in preventing nausea and vomiting in women receiving moderately emetogenic chemotherapy? Findings In this randomized phase 3 clinical trial that
Deshen Wang +13 more
semanticscholar +1 more source
Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes
Advanced Functional Materials, EarlyView.Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth +2 more
wiley +1 more source
Impact of Nausea and Vomiting on Quality of Life in Cancer Patients During Chemotherapy
Health and Quality of Life Outcomes, 2003 It is commonly claimed that the nausea and vomiting accompanying cytotoxic chemotherapy have a negative impact on health-related quality of life. While this may seem self-evident, until a few years ago there was little empirical data demonstrating that ...
Roila Fausto, Ballatori Enzo
doaj +1 more source